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paul.dimitri@sch.nhs.ukSummaryXanthogranulomatous hypophysitis (XGH) is a very rare form of pituitary hypophysitis that may present both clinically
and radiologically as a neoplastic lesion. It may either be primary with an autoimmune aetiology and can occur in isolation or
as a part of autoimmune systemic disease or secondary as a reactive degenerative response to an epithelial lesion
(e.g. craniopharyngioma (CP), Rathke’s cleft cyst, germinoma and pituitary adenomas) or as a part of a multiorgan systemic
involvement such as tuberculosis, sarcoidosis or granulomatosis. It may also present with a variation of symptoms in
children and adults. Our case series compares the paediatric and adult presentations of XGH and the differential diagnoses
considered in one child and two adult patients, highlighting the wide spectrum of this condition. Endocrine investigations
suggested panhypopituitarism in all three patients and imaging revealed a suprasellar mass compressing the optic chiasm
suggestive of CP or Rathke’s cleft cyst in one patient and non-functioning pituitary macroadenoma in two patients. Magnetic
resonance imaging (MRI) demonstrated mixed signal intensities on T1- and T2-weighted sequences. Following endoscopic
transsphenoidal surgery, histological analysis revealed necrotic material with a xanthogranulomatous reaction confirming
XGH in two patients and a necrobiotic granulomatous chronic inflammatory infiltrate with neutrophils in one patient,
which is not typical of current descriptions of this disorder. This case series describes the wide spectrum of XGH disease that
is yet to be defined. Mixed signal intensities on T1- and T2-weighted MRI sequences may indicate XGH and diagnosis is
confirmed by histology. Histological variation may indicate an underlying systemic process.Learning points:
† XGH is a rare form of pituitary hypophysitis with a wide clinical and histological spectrum and can mimic a
neoplastic lesion.
† XGH primarily presents with growth arrest in children and pubertal arrest in adolescents. In adults, the presentation
may vary.
† A combination of hypopituitarism and mixed signal intensity lesion on MRI is suggestive of XGH and should be
considered in the differential diagnosis of sellar lesions.
† Radical surgery is the treatment of choice and carries an excellent prognosis with no recurrence.http://www.edmcasereports.com
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Pituitary hypophysitis is a rare, inflammatory condition
that may present both clinically and radiologically as a
neoplastic lesion (1). Clinically, it is associated with
headaches and visual disturbance due to the local mass
effect and compression of the optic chiasm. Pituitary
dysfunction secondary to inflammatory infiltration is
common.
Hypophysitis is histologically divided into the
following five distinct categories: lymphocytic, granulo-
matous, xanthomatous, necrotising and xanthogranulo-
matous hypophysitis (XGH), with the latter being
a mixture of the xanthomatous and granulomatous
subtypes (2). They are also classified as either adenohypo-
physitis or infundibuloneurohypophysitis based on their
anatomical location and areas of infiltration (2). Lympho-
cytic hypophysitis is the most common type (1); XGH is
rare and characterised by cholesterol clefts, haemosiderin
deposits, multinucleated giant cells, macrophage accumu-
lation and fibrous proliferation (3). Its pathogenesis is
unclear and aetiologically it can either be a primary (most
common) or a secondary hypophysitis. Primary hypophy-
sitis is autoimmune in origin and can occur in isolation
or as a part of systemic disease such as polyglandular
autoimmune syndromes or IgG4 systemic disease (4).
Secondary hypophysitis is thought to occur as a con-
sequence of local inflammation caused by lesions includ-
ing craniopharyngioma (CP)/Rathke’s cleft cyst or as a
part of systemic diseases such as tuberculosis, sarcoidosis,
Wegener’s granulomatosis or syphilis (4) (5).
In this case series, we describe three patients with
XGH of different aetiologies, demonstrating variable
clinical presentation depending on the age of diagnosis
and the spectrum of histological presentation of XGH.Case presentation
Patient 1
A 14-year-old female was initially referred with an
18-month history of lethargy, reduced appetite, abdomi-
nal pain, bloating and nausea. She developed a headache
at a later stage that was not associated with vomiting,
visual symptoms or neurological deficit. Her significant
concerns at presentation were primary amenorrhoea and
lack of pubertal progression reporting no progressive
breast development since 11 years. On examination her
height was 151 cm (K1.73 SDS) and weight was 33 kg
(K3.36 SDS) with a BMI of 14 kg/m2 (K3.03 SDS).http://www.edmcasereports.comHer pubertal assessment showed her to be at Tanner breast
stage 3, with no axillary or pubic hair. A previously
performed thyroid function test had revealed a low free
thyroxine (T4) (8.9 pmol/l) and an inappropriately low
TSH (2.3 IU/l) suggestive of central hypothyroidism.
Subsequent dynamic pituitary function tests confirmed
anterior hypopituitarism (Table 1) and she was com-
menced on hydrocortisone (10 mg/m2) and levothyroxine
(50 mg daily) replacement. Steroid replacement unmasked
her background diabetes insipidus both clinically and
biochemically (Table 1) and she was commenced on
desmopressin 100 mg twice daily. Her TW3 bone age was
delayed by 2 years. Formal visual assessment showed
bitemporal quadrantanopia worse on the left than on the
right. Cranial magnetic resonance imaging (MRI) revealed
a suprasellar mass compressing the optic chiasm with a
relatively uniform high-signal intensity on T1- and T2-
weighted sequences (Fig. 1A and B). Differential diagnoses
considered based on these findings were pituitary macro-
adenoma, CP or a Rathke’s cleft cyst. Endoscopic
transsphenoidal surgery was performed in order to
preserve her vision and obtain a formal diagnosis.
Histopathology of the resected lesion showed reactive
changes with necrotic material and cholesterol clefts
suggestive of xanthogranuloma of the sellar region.
Haemosiderin was observed and, although multinucleate
cells were around some cholesterol clefts, these were not
prominent (Table 2 and Fig. 4A). Gram stain (for bacteria),
Warthin–Starry stain (for treponemes) and Ziehl–Neelsen
stain (for TB) were all negative. Histology did not
demonstrate evidence of vasculitis or granuloma forma-
tion, therefore ruling out sarcoidosis and Wegener’s
granulomatosis as the other biochemical tests were not
performed.
She made an excellent recovery following hormone
replacement and surgery. She has shown remarkable catch
up growth (height velocity 9.36 cm/year) following
growth hormone (0.7 mg/m2 per day) treatment. She is
due to commence oestrogen replacement. An MRI scan
performed 6 months post-surgery demonstrated signi-
ficant decompression of the chiasm and a thin line of
pituitary tissue in the base of the pituitary fossa.Patient 2
A 21-year-old woman with a past medical history of poorly
controlled type 1 diabetes mellitus (HbA1cZ11.2%) was
investigated at her local hospital after reporting amenorr-
hoea for 3 years following the birth of her child.
In addition, she gave a history of lethargy and frontal2
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Figure 1
(A and B) MRI image of patient 1 demonstrating the pituitary lesion
pre-surgery.
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DOI: 10.1530/EDM-14-0089headaches. Endocrinological investigations demonstrated
anterior pituitary dysfunction with adrenal insufficiency,
hypothyroidism, growth hormone deficiency, hypogona-
dotropic hypogonadism and hyperprolactinaemia with a
prolactin level of 2207 mIU/l (Table 1). She was therefore
commenced on hydrocortisone (11.8 mg/m2), T4 75 mg
daily and cabergoline 0.25 mg twice weekly, which
markedly improved her symptoms; she continued on
oestrogen and progesterone hormone replacement
therapy. She subsequently reported having a severe,
sudden onset headache with transient loss of vision
suggestive of pituitary apoplexy. Cranial MRI scan
revealed an 18!14!19 mm pituitary lesion, with supra-
sellar extension and superior displacement of the optic
chiasm (Fig. 2A and B). Despite compression of the optic
tract, visual fields and visual acuity were unaffected. She
was subsequently referred to the regional pituitary
specialist team and a diagnosis of a non-functioning
pituitary macroadenoma was made. She underwent
endoscopic transsphenoidal surgery. Histological analysis
of the resected lesion demonstrated areas of cholesterol
cleft formation associated with multinucleate giant
cells and numerous macrophages, highlighted byTable 2 Summary of histological features.
Case Necrosis
Cholesterol
clefts Fibrosis Haemosiderin gr
Patient 1 C C C C
Patient 2 C C C C
Patient 3
Biopsy 1 C K C C
Biopsy 2 C K C K
aSeparate to cholesterol clefts.
http://www.edmcasereports.comimmunohistochemistry to CD68. Areas of necrotic tissue,
fragments of fibrous tissue, and the residual compressed
adenohypophysis were also present (Fig. 4B and C). Gram
stain (for bacteria), Warthin–Starry stain (for treponemes)
and Ziehl–Neelsen stain (for TB) were all negative.
Histology did not demonstrate evidence of vasculitis or
granuloma formation, therefore ruling out sarcoidosis and
Wegener’s granulomatosis as the other biochemical tests
were not performed.
Shemade a full post-operative recovery and continued
on hydrocortisone, T4 and HRT. She developed diabetes
insipidus post-surgery. An MRI scan performed 6 months
following surgery demonstrated normal pituitary gland,
stalk and chiasm with no residual lesion (Fig. 2C).Patient 3
A 67-year-old man was diagnosed with hypopituitarism
following an episode of collapse and intermittent
temporal headaches. His pituitary MRI at the time of
presentation revealed an enlarged gland with cystic
appearance consistent with an adenoma. He was com-
menced on replacement therapy with T4 50 mg daily,
hydrocortisone 10.5 mg/m2 and testosterone 50 mg daily
initially followed by testosterone enanthate 1000 mg
injections every 3 months. He developed partial diabetes
insipidus 6 months after diagnosis, which was confirmed
by an abnormal water deprivation test with urine
osmolality increasing only to 346 mOsm/kg with a paired
serum osmolality of 302 mmol/kg; post-DDAVP urine
osmolality was 707 mOsm/kg. He had a past medical
history of rheumatoid arthritis diagnosed at 53 years,
hypertension and bladder outflow obstruction. A transur-
ethral resection of prostate (TURP), at the age of 56,
showed granulomatous changes consistent with the
development of rheumatoid nodules within the prostate.
His prostate-specific antigen (PSA) levels were monitored
relating to his testosterone replacement. A sudden rise inVague
anuloma
Multinucleate
giant cellsa
Prominent
foamy
macrophage Neutrophils Eosinophils
K K K K K
K C K K K
C C C C C
K C C C C
4
Figure 2
(A and B) MRI image of patient 2 demonstrating the pituitary lesion pre-surgery. (C) MRI image of patient 2 demonstrating the pituitary lesion post-surgery.
Figure 3
(A and B) MRI image of patient 3 demonstrating the pituitary lesion
post-surgery.
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which was managed with testosterone blockage and
radical radiotherapy. He subsequently developed osteo-
porosis and was treated with bisphosphonates, calcium
and vitamin D supplements.
After 1 year, he presented with an apoplectic event
associated with the sudden onset of a vomiting episode
followed by a significant headache similar to the one he
experienced at the time of his initial presentation.
Following that he felt extremely weak and lethargic and
continued to experience worsening severe headaches.
A repeat MR scan showed a significant enlargement of
the pituitary mass, elevating the optic chiasmmore on the
right. The chiasm was oedematous and enlarged along
with the proximal portion of the right optic nerve.
Following gadolinium contrast, the tumour had a hetero-
geneous pattern of enhancement with a low-signal centre
suggesting central necrosis; there was, however, no
evidence of intratumoural haemorrhage. Visual exami-
nation was normal. Histological examination of the mass
removed by the transsphenoidal approach revealed a
florid, mixed inflammatory infiltrate composed predomi-
nantly of lymphocytes and plasma cells with some
admixed neutrophils and eosinophils. No well-formed
granuloma was observed although loose areas of epithelial
macrophage aggregates were present in a vaguely granulo-
matous manner and occasional multinucleate giant cells,
partly foamy (Touton-like), were observed (Fig. 4D, E and F).
No adenoma or other neoplastic elements were observed
and special stains for bacteria, fungi and mycobacteria
were negative. Epithelial cell markers were negative. A
histological diagnosis of hypophysitis with a mixed
inflammatory cell infiltrate was made.
Persistence of severe right temporal and orbital pain
for a year led to further transsphenoidal surgery; the
histology findings showed a dense inflammatory infiltrate
of lymphocytes, plasma cells and histiocytes, withhttp://www.edmcasereports.comscattered polymorphs (Fig. 3A and B). There were also
xanthomatous and multinucleate macrophages, but with-
out well-formed granuloma (Fig. 4G and H). In view of the
progressive nature of this inflammatory process with
sclerosis and lymphoplasmacytic infiltrate, immunohisto-
chemical staining for IgG4 was performed, which showed
IgG4-positive plasma cells (O5%), raising possibility of a
systemic IgG4-related process. However, the proportion of
IgG4-positive cells was not as high as that mentioned in
some of the previous reports (often 80%) and the serum
IgG4 level was also not raised, hence a primary IgG4-
related sclerosing disease was thought unlikely.
He showed good response to high-dose steroids with
prednisolone and immunosuppressive therapy with
methotrexate.Investigation
Investigations performed on all three patients are sum-
marised in Table 1 and reference values in Table 3. All
three patients demonstrated evidence of anterior hypo-
pituitarism at the time of diagnosis. Steroid replacement5
Table 3 Reference values of the various tests carried out.
Tests Reference ranges
Prolactin (mIU/l) 102–496
Cortisol (nmol/l) 198–720
ACTH (ng/l) 0000 h!15; 0900 h!46
Serum osmolality (mmol/kg) 275–295
Urine osmolality (mOsmol/kg) 100–800
Serum sodium (mmol/l) 133–144
HbA1c (mmol/mol) 19–48
Random glucose (mmol/l) !11.1
ACE (IU/l) 12–68
Follicular phase
FSH (IU/l) 3.5–13.0
LH (IU/l) 2.4–13.0
Oestradiol (pmol/l) 46–607
Ovulation phase
FSH (IU/l) 4.7–22.0
LH (IU/l) 14.0–96.0
Oestradiol (pmol/l) 315–1828
Luteal phase
FSH (IU/l) 1.7–7.7
LH (IU/l) 1.0–11.0
Oestradiol (pmol/l) 161–774
Post-menopausal
FSH (IU/l) 26–135
LH (IU/l) 7.7–59
Oestradiol (pmol/l) 18.4–201
Patient 1
TSH (IU/l) 0.5–3.6
FT4 (pmol/l) 10.0–16.9
FT3 (pmol/l) 3.4–6.5
IGF1 (mg/ml) 284–713
Patient 2
TSH (IU/l) 0.27–4.2
FT4 (pmol/l) 12.0–22.0
FT3 (pmol/l) 3.1–6.8
IGF1 (mg/ml) 115–340
Patient 3
TSH (IU/l) 0.35–4.5
FT4 (pmol/l) 10.3–21.9
FT3 (pmol/l) 3.1–6.8
IGF1 (mg/ml) 52–227
A
HG
FE
DC
B
100 µm
100 µm
50 µm
100 µm 50 µm
50 µm
100 µm
Figure 4
(A) Patient 1. Haematoxylin and eosin-stained section showing numerous
cholesterol clefts (arrowheads). Brown, haemosiderin pigment is present
(arrow) and there is an area of necrosis (star). Scale bar, 100 mm. (B and C)
Patient 2. In addition to cholesterol clefts, there is an aggregate of
multinucleate giant cells (arrow, B). In C, the cholesterol clefts are
associated with new fibrosis. Scale bars, 100 mm. (D, E and F) Patient 3,
first biopsy. An area of lymphoplasmacytic cells surrounded by paler
macrophages, with a loose, vague granulomatous appearance (D, scale bar,
100 mm). In areas, foamy macrophages are admixed with neutrophils
(E, scale bar, 50 mm), while F shows a somewhat foamy multinucleate
macrophage (arrow) in a background of lymphocytes, histiocytes and
plasma cells (scale bar, 50 mm). (G and H) Patient 3, second biopsy. Low-
power view (G) showing dense fibrous tissues with a lymphoplasmacytic
infiltrate. There is an area of necrosis towards the top of the field (scale bar,
100 mm). At high power (H), there is a prominent foamy macrophage
infiltrate with admixed lymphocytes and histiocytes.
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developed diabetes insipidus post surgery.
All three patients underwent endoscopic transphenoi-
dal resection of the mass followed by hormone replace-
ment therapy with good effect. Patient 3, in view of his
underlying autoimmune systemic involvement was alsohttp://www.edmcasereports.comtreated with high dose steroids and immunosuppressants
with good effect.
Patients 1 and 2 made an excellent recovery following
surgery and hormone replacement. Patient 3 developed
recurrence one year post surgery. He showed good
response to high dose steroids and immunosuppressants
along with hormone replacement.Discussion
Hypophysitis is a rare, inflammatory condition of the
pituitary that mimics neoplastic lesions resulting in
anterior and posterior pituitary dysfunction. Of the
different subtypes, lymphocytic hypophysitis is the most6
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disease (5). XGH is the least common subtype and is
reported to occur predominantly in young adults (6) (7).
In this case series, we report three patients (one child and
two adults) with XGH resulting from different aetiologies.
XGH can present as i) a separate entity as described in our
first patient, ii) a secondary reaction to a local process such
as apoplexy as described in our second patient and
iii) progression of inflammation of a systemic condition
with an autoimmune aetiology as described in our third
patient. While the pathologies of patients 1 and 2 were
similar, case 3 showed some distinctive features, namely
a lack of cholesterol clefts, more mixed inflammatory cells
and more prominent foamy macrophages. Vague granu-
lomatous inflammation, differing from the aggregates of
multinuclear macrophages seen with (and separate from)
cholesterol clefts, was also a feature in patient 3. As with
other lesions of the pituitary gland, the clinical presen-
tation of XGH is age dependent, particularly in relation
to the impact on growth hormone and gonadotrophin
secretion resulting in short stature and pubertal arrest
in children.
Thus far, only six cases of XGH have been reported in
detail in children between the age of 5 and 12 years (7) (8).
Of the six children, four out of six had DI as an isolated
endocrine dysfunction pre-operatively; one child pre-
sented with short stature. In our case series, we observed
more pan-pituitary involvement with the younger patient
than has been reported previously. The difference in
presentation between paediatric and adult patients reflects
the functional impact of pituitary hormone deficiency.
Our paediatric patient presented with growth failure and
pubertal arrest, whereas our adult patients presented with
variable symptoms and signs relating to anterior and
posterior pituitary dysfunction. Interestingly, the consist-
ent presentation in these patients was frontal headache.
XGH does not have sex preponderance and has been
reported previously in both sexes across all age groups (7).
The rarity of this lesion is perhaps in part due to the
relatively recent discovery of this inflammatory subtype of
hypophysitis. Tashiro et al. were the first group to report
the entity of XGH in 2002 following the retrospective
analysis of 31 hypophysitis cases, revealing two specimens
consisting of multinucleated giant cells, epithelioid cells
and lymphocytic infiltration, consistent with granuloma-
tous hypophysitis. In addition, cholesterol clefts (xantho-
matous cells) were present within these tissue samples and
thus the new histological category of XGHwas created (2).
Subsequently, a few cases of XGH have been reported with
typical histopathological findings of cholesterol clefts,http://www.edmcasereports.comhaemosiderin deposits, multinucleated giant cells and
only small epithelial cell clusters (7) (8) (9) (10).
Infiltration of both the adeno- and neuro-hypophysis
explains the clinical correlation with headaches, anterior
pituitary dysfunction and diabetes insipidus observed in
previous patients and our reported cases with XGH (2) (7)
(11) (12) (13). Cases of isolated anterior pituitary dysfunc-
tion, as reported in our case series (patient 2), have also
been described previously (14). In previous case reports,
tumour size and the extent of infiltration do not appear to
correlate with endocrine dysfunction; however, patients
diagnosed with XGH are reported to present with more
extensive hypopituitarism when compared with those
with non-XGH (14). Xanthogranulomatous lesions are
more commonly found in other parts of the body
including the skin, skull, choroid plexus, orbit and
gallbladder (6). Lesions may be present in more than one
location as demonstrated by a previous coincidental
finding of xanthogranuloma of the skin and pituitary in
a 64-year-old male, which may give further clues to the
diagnosis of pituitary XGH (14).
The pathogenesis and histogenesis of XGH still
remain unclear. Pituitary XGH may develop spon-
taneously as described in our first patient or as a secondary
reaction to haemorrhage, tissue necrosis or severe inflam-
mation following leak of cystic contents into the
surrounding tissue in pre-existing lesions such as CPs,
adenomas or Rathke’s cleft cysts (6) (14) (15) (16) (21). This
may explain the origin of the lesion in our second patient
as she did experience an episode suggestive of apoplexy,
which may have triggered xanthogranulomatous infiltra-
tion. Zada et al.have recently reviewed the developmental
relationships and differentiating features of various
epithelial lesions of the sellar region including CP,
Rathke’s cleft cyst, xanthogranuloma, and dermoid and
epidermoid cysts. They highlighted that XGH represents
approximately 34% of the suspected cases of CP and
the recurrence rate is unknown. The lesion is mainly
composed of xanthogranulomatous component with
minimal squamous epithelium (17).
XGH can also arise as part of a systemic condition with
autoimmune aetiology that presents with different find-
ings in relation to XGH on histological examination as
described in our third patient. A differential diagnosis of
IgG4 disease was considered in view of the progressive
nature of the inflammatory process with histological
findings of pituitary lymphoplasmacytic infiltrate and
sclerosis with an increased proportion of IgG4-positive
plasma cells (O5%) raising the possibility of IgG4-related
sclerosing disease. Previous reports have shown that7
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common finding in orbital xanthogranuloma as part of
a primary xanthogranulomatous process (18) (19).
An elevated proportion of IgG4 plasma cells have also
been found in some tissues in association with
rheumatoid disease, though data for pituitary are lacking.
Hence, the presence of IgG4 plasma cells in our patient
may be a result of xanthogranulomatous change or
secondary to rheumatoid arthritis. The xanthomatous
macrophage component of this patient differed from our
other reported patients, perhaps reflecting a histological
variation in XGH, though the spectrum of the XGH
disease is yet to be defined.
Cholesterol deposits typically show as T1 high- or T2
high-signal intensities on MRI, whereas the haemosiderin
appears isointense on T1 and hypointense on T2 images.
Granulation tissue, however, appears hypointense on
both T1 and T2 respectively (14). Given the complex
architecture of xanthogranulomatous lesions, the MRI
appearance is usually of mixed signal intensities on T1-
and T2-weighted sequences consistent with the MRI
findings in our patients (7) (8) (14). CP may also contain
cholesterol clefts that appear hyperintense on MRI (10),
therefore making it difficult to radiologically differentiate
from XGH. However, the coexistence of haemosiderin
deposits and absence of abundant epithelial cells should
aid in delineating these two lesions by MRI.
Evidence suggests radical surgery as the treatment
modality of choice for XGH resulting in complete
remission without any recurrence (6) (17) (20). Post-
operative obesity is not encountered in XGH, as changes
are usually limited to the anterior hypothalamus when
compared with CP, where the posterior hypothalamus is
predominantly involved (20). The transsphenoidal
approach to surgery may also reduce the risk of compli-
cations (20). Though the 5-year overall survival rate has
been reported as 1.00G0.00 in both XGH and CP, the
event-free survival rate in terms of relapse or residual
tumour progression is much higher in XGH (1.00G0.0)
when compared with CP (0.52G0.05) (20).Conclusion
Xanthogranulomatous inflammatory lesions of the
pituitary are rare causes of pituitary dysfunction and
can mimic neoplastic lesions. The clinical presentation in
children and adults may vary in relation to the extent of
the pituitary damage and clinical presentation in relation
to the hormone pathways affected. Our case series
highlights that a combination of hypopituitarism andhttp://www.edmcasereports.coma mixed signal intensity lesion on MRI is suggestive of
XGH and should therefore be considered in the
differential diagnosis of sellar lesions as surgical inter-
vention carries an excellent prognosis with no
recurrence. The histological variation in XGH lesions
may require further classification in relation to the
underlying disease process.Declaration of interest
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